Early-onset seizures-distal limb anomalies-facial dysmorphism-global developmental delay syndrome
A rare genetic multiple congenital anomalies/dysmorphic syndrome characterized by variable developmental delay intellectual disability early-onset seizures and facial dysmorphism (including arched eyebrows long palpebral fissures prominent nasal bridge large ears thin upper lip and high arched palate). Other reported features are microcephaly hypotonia growth retardation congenital heart defects and malformations of the fingers and toes as well as additional neurologic manifestations (such as ataxia or spastic quadriplegia). Brain imaging may show hypoplastic corpus callosum white matter abnormalities or cortical atrophy.
Data from Orphanet are used to provide information on a disease's name, synonym(s), and overview.
Orphadata: Free access data from Orphanet. © INSERM 1999. Available on http://www.orphadata.org. Data version December 2023
Newly diagnosed with
Early-onset seizures-distal limb anomalies-facial dysmorphism-global developmental delay syndrome?
Our RARE Concierge Services Guides are available to assist you by providing information, resources and connections as you navigate your rare disease journey.
COMBINEDBrain is a consortium for outcome measures and biomarkers for neurodevelopmental disorders. We are collaborating to cure rare, non-verbal brain disorders.
Our mission is to connect families, resources, and the medical community to advance research for a treatment or cure to DDX3X Syndrome. Our ultimate goal is to accelerate brain function in individuals affected by DDX3X Syndrome through advances in cell and gene therapy and pharmaceuticals.
Genetic Epilepsy Team Australia
Collaboration of research and care
Moonshots for Unicorns
Curing single-gene disorders
To fund research for treatment and/or a cure for CASK Gene Disorder
Syndromes Without A Name (SWAN) Australia
Provide information, support and advocacy to families caring for a child with an undiagnosed or rare genetic condition.
For a list of clinical trials in this disease area, please click here.